ReviewExpert review of clinical immunology2019

Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome.

Chelsea Kotch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.